OPEN END TURBO LONG - AMGEN | Market Closed - Börse Stuttgart 01:22:35 04/07/2024 am IST | ||
| 16.88 EUR | -1.80% |
|
| Current month | -1.75% | ||
| 1 month | +1.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 16.88 | -1.80% |
| 02/24/02 | 17.19 | +0.29% |
| 01/24/01 | 17.14 | -0.23% |
| 28/24/28 | 17.18 | -1.09% |
| 27/24/27 | 17.37 | -0.63% |
Delayed Quote Börse Stuttgart
Last update July 04, 2024 at 01:22 am IST
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MC9VJC |
| ISIN | DE000MC9VJC5 |
| Date issued | 07/01/2021 |
| Strike | 127.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8.64 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.51 € |
|---|---|
| Lowest since issue | 7.16 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.4
USD
Spread / Average Target
+2.28%
- Stock Market
- Certificates
- Certificat
